Cell proliferation indexes: A biomarker in solid tumors

Biotechnic and Histochemistry

Volumn 72, Issue 2, 1997, Pages 78-85

  Elias, Jules M ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

biomarkers; cell proliferation; chemoprevention; solid tumors

Indexed keywords

CANCER CHEMOTHERAPY; CANCER SURVIVAL; CARCINOGENESIS; CELL PROLIFERATION; CONFERENCE PAPER; DIAGNOSTIC VALUE; HUMAN; MITOSIS; SOLID TUMOR;

EID: 0030950925     PISSN: 10520295     EISSN: None     Source Type: Journal    
DOI: 10.3109/10520299709082216     Document Type: Conference Paper

References (58)

1. Anti, M., Giancarlo, M., Percesepe, A., Armelao, F. and Gasbarrini, G. 1994. Reliability of rectal epithelial kinetic patterns as an intermediate biomarker of colon cancer. J. Cell. Biochem. S19: 68-75.
2. Baak, J. P. A. 1990. Mitosis counting in tumors (editorial). Hum. Pathol. 21: 683-685.
3. Beronese, S. M. and Gambacorta, M. 1991. Detection of Ki-67 proliferation rate in breast cancer. Correlation with clinical and pathologic features. Am. J. Clin. Pathol. 95: 30-34.
4. Boone, C. W. and Kelloff, G. J. 1994. Development of surrogate endpoint biomarkers for clinical trials of cancer chemopreventive agents: relationships to fundamental properties of preinvasive (intraepithelial) neoplasia. J. Cell. Biochem. S19: 10-22.
5. Bravo, R. and MacDonald-Bravo, H. 1987. Existence of two populations of cyclin/proliferation cell nuclear antigen during the cell cycle: association with DNA replication sites. J. Cell Biol. 105: 1549-1554.
6. Brown, R. D., Linden, M. D., Mackowiak, P., Kubus, J. J., Zarbo, R. J. and Rabinovitch, P. S. 1996. The effect of number of histogram events on reproducibility and variation of flowcytometric proliferation measurement. Am. J. Clin. Pathol. 105: 696-704.
7. Buset, M., Lipkin, M., Winawer, S., Swaroop, S. and Freidman, E. 1986. Inhibition of human colonic epithelial cell proliferation in vivo and in vitro by calcium. Cancer Res. 46: 5426-5430.
8. Campbell, J. L. 1993. Yeast DNA replication. J. Biol. Chem. 268: 25261-25264.
9. Coltera, M. D., Skelly, M. and Gown, A. M. 1993. Anti-PCNA yields unreliable proliferation indexes in routinely processed, deparaffinized, formalin-fixed tissue. Appl. Immunohistochem. 1: 193-200.
10. Costa, A., Silvestrini, R., Moche, N. C., Lequaglie, C., Boracchi, P., Faranda, A., Vessecchia, G. and Ravasi, G. 1996. p53 expression, DNA ploidy and S-phase cell fraction in operable locally advanced non-small-cell lung cancer. Brit. J. Cancer 73: 914-919.
11. DePamphilis, M. L. 1993. Eukaryotic DNA replication: anatomy of an origin. Ann. Rev. Biochem. 62: 29-63.
12. Durie, B. G. M. 1986. Staging and kinetics of multiple myeloma. Semin. Oncol. 13: 300-309.
13. Elias, J. M., Conkling, K. and Makar, M. 1972. Cold Feulgen hydrolysis: its effect on displacement of tritiated thymidine. Acta Histochem. Cytochem. 5: 125-131.
14. Ellis, P. A., Makris, A., Burton, S. A., Titley, J., Ormerod, M. G., Salter, J., Powles, T. J. Smith, I. E. and Dowsett, M. 1996. Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomas. Brit. J. Cancer 73: 640-643.
15. Fairman, M. P. 1990. DNA polymerase delta/PCNA: actions and interactions. J. Cell Sci. 95: 1-4.
16. Gerdes, J., Schwab, U., Lemke, H. and Stein, H. 1983. The production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer 31: 13-20.
17. Gerdes, J., Li, L., Schlueter, C., Duchrow, M., Wohlenberg, C., Gerlach, C., Stahmer, I., Kloth, S., Brandt, E. and Flad, H.-D. 1991. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am. J. Pathol. 138: 867-73.
18. Gestblom, C., Hoehner, J. C. and Pahlman, S. 1995. Proliferation and apoptosis in neuroblastoma: subdividing the mitosis-karyorrhexis index. Eur. J. Cancer 31A: 458-463.
19. Hall, P. A., Gregory, W., Richards, M. A., d'Ardenne, A. J., Lister, T. A. and Stansfeld, A. G. 1988. The prognostic significance of Ki-67 immunostaining in non-Hodgkin's lymphoma. J. Pathol. 154: 223-235.
20. Hanada, K., Itoh, M., Fujii, K., Tsuchida, A., Ishimaru, S., Hirata, M. and Kajiyama, G. 1995. Expression of the proliferative cell nuclear antigen (PCNA) in adenocarcinoma of the gall bladder and its relationship to prognosis. Scand. J. Clin. Lab. Invest. 55: 377-382.
21. Hedley, D. W. 1989. Flow cytometry using paraffin-embedded tissue: five years on. Cytometry 31: 229-241.
22. Hepburn, P. J., Glynne-Jones, E., Goddard, L., Gee, J. M. and Harper, M. E. 1995. Cell proliferation in prostatic carcinoma: comparative analysis of Ki-67, MIB-1, and PCNA. Histochem. J. 27: 196-203.
23. Keloff, G. J., Boone, C. W., Crowell, J. A., Steele, V., Lubet, R. and Doody, L. A. 1994. Surrogate endpoint biomarkers for phase II cancer chemoprevention trials. J. Cell. Biochem. S19: 1-9.
24. Kitchell, M. L. and Dibner, J. J. 1989. Rapid detection of proliferating cells using microwave fixation with a monoclonal antibody to bromodeoxyuridine. J. Histotechnol. 12: 101-103.
25. Konishi, N., Nakaoka, S. M., Tsuzuki, T., Kitahori, Y., Nishii, K., Kitamura, M., Oshima, M. and Hiasa, Y. 1994. Progressive activity in latent prostate carcinoma defined by argyrophilic staining of the nuclear organizer regions (AgNOR). Pathol. Int. 44: 297-302.
26. Lacy, E. R., Kuwayama, H., Cowart, K. S., King, J. S., Deutz, A. H. and Sistrunk, S. 1991. A rapid accurate immunohistochemical method to label proliferating cells in the digestive tract. A comparison with tritiated thymidine. Gastroenterology 100: 259-262.
27. Leong, A. S.-Y. and Lee, A. K. C. 1995. Biological indices in the assessment of breast cancer. J. Clin. Pathol. 48: M221-M238.
28. Levine, A. J. and Broach, J. R. 1995. Oncogenes and cell proliferation. Editorial overview. Curr. Opin. Genet. Dev. 5: 1-4.
29. Lloveras, B., Edgerton, S. and Thor, A. D. 1991. Evaluation of in vitro bromodeoxyuridine labeling of breast carcinomas with the use of a commercial kit. Am. J. Clin. Pathol. 95: 41-47.
30. Louis, D. N., Edgerton, S., Thor, A. D. and Heldley-Whyte, E. T. 1991. Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: a comparative study. Acta Neuropathol. 81: 675-679.
31. Maasken, A. P. and Deschner, E. E. 1977. Tritiated thymidine incorporation into epithelial cells of normal appearing colorectal mucosa of cancer patients. J. Natl. Cancer Inst. 58: 1221-1224.
32. Mamev, N. N. and Mamaeva, S. E. 1990. Nucleolar organizer region activity in human chromosomes and interphase nuclei of normal, leukemic and tumor cells as evaluated by silver staining. Int. Rev. Cytol. 121: 233-261.
33. McNeal, J. E., Haillot, O. and Yemoto, C. 1995. Cell proliferation in dysplasia of the prostate: analysis by PCNA immunostaining. Prostate 27: 258-268.
34. Medina, F.-J., Cerdido, A. and Marco, R. 1995. Microwave irradiation improvements in the silver staining of the nucleolar organizer (Ag-NOR) technique. Histochemistry 103: 403-413.
35. Meyer, J. S. and Conner, R. E. 1977. In vitro labeling of solid tissues with tritiated thymidine for autoradiographic detection of S-phase nuclei. Stain Technol. 52: 185-195.
36. Meyer, J. S., Nauert, J., Kohem, S. and Hughes, J. 1989. Cell kinetics of human tumors by in vitro bromodeoxyuridine labeling. J. Histochem. Cytochem. 37: 1449-1454.
37. Mourad, W. A., Connelly, J. H., Sembera, D. L., Atkinson, E. N. and Brunner, J. M. 1993. The comparison of two argyrophilic nucleolar organizer region counting methods with bromodeoxyuridine labeling index: a study of metastatic tumors of the brain. Hum. Pathol. 24: 206-210.
38. Polkowski, W., van Lanschot, J. J., Ten Kate, F. J., Baak, J. P., Tygat, G. N., Obertop, H., Voorn, W. J. and Offerhaus, G. J. 1995. The value of p53 and Ki67 as markers for tumor progression in the Barret's dysplasia-carcinoma sequence. Surg. Oncol. 4: 163-171.
39. Qing, L., Hacker, G. W., Danscher, G., Sonnleitner-Wittauer, U. and Grimelius, L. 1995. Argyrophilic nucleolar organizer regions. A revised version of the Ag-NOR-staining technique. Histochem. Cell. Biol. 104: 145-150.
40. Risio, M. 1994. Methodological aspects of using immunohistochemical cell proliferation biomarkers in colorectal carcinoma chemoprevention. J. Cell. Biochem. S19: 61-67.
41. Rose, D. S. C., Maddox, P. H. and Brown, D. C. 1994. Which proliferation markers for routine immunohistology? A comparison of five antibodies. J. Clin. Pathol. 47: 1010-1014.
42. Ross, W. and Hall, P. A. 1995. Ki-67: from antibody to molecule to understanding. J. Clin. Pathol: Clin. Mol. Pathol. 218: M113-M117.
43. Shi, S. R., Key, M. E. and Kalra, K. L. 1991. Antigen retrieval in formalin fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J. Histochem. Cytochem. 39: 741-748.
44. Shin, D. M., Voravud, N., Ro, J. Y., Lee, J. S., Hong, W. K. and Hittleman, W. N. 1993. Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker. J. Natl. Cancer Inst. 85: 971-978.
45. Silverstrini, R. 1994. SICCAB Group quality control of cell kinetic determinations. Quality control for evaluation of the S-phase fraction by flow cytometry: a multimeric study. Cytometry 18: 11-16.
46. Sirvent, J. J., Salvado, M. T., Santefe, M., Martinez, S., Brunet, J., Alvaro, T. and Palacios, J. 1995. p53 in breast cancer. Its relation to histological grade, lymph-node status, hormone receptors, cell-proliferation fraction (Ki-67) and cerbB-2. Immunohistochemical study of 153 cases. Histol. Histopathol. 10: 531-539.
47. Soini, Y., Virkajarvi, V.-P., Lehto, V. P. and Paakko, P. 1996. Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival. Brit. J. Cancer 73: 1025-1030.
48. Tannapfel, A., Hahn, H. A., Katalnic, A., Feitkau, R. J., Kuhn, R. and Wittekind, C. W. 1996. Prognostic value of ploidy and proliferation markers in renal cell carcinoma. Cancer 77: 164-171.
49. Taylor, J. H. 1962. Chromosome reproduction. Int. Rev. Cytol. 13: 39-44.
50. Thor, A. D. and Lloveras, B. 1991. How should bromodeoxyuridine labeling be counted? Am. J. Clin. Pathol. 96: 435-436.
51. Tsurimoto, T. and Stillman, B. 1989. Multiple replication factors augment DNA synthesis by the two eukaryotic DNA polymerases alpha and delta. EMBO J. 8: 3883-3889.
52. Tubiana, M. and Courdi, A. 1989. Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long-term survival. Radiother. Oncol. 15: 1-18.
53. Wakimoto, H., Aoyagi, M., Nakayama, T., Nagashima, G., Yamamoto, S., Tamaki, M. and Hirawaka, K. 1996. Prognostic significance of Ki-67 labeling indices obtained using MIB1 monoclonal antibody in patients with supratentorial astrocytomas. Cancer 77: 373-380.
54. Wang, T. A. and Li, J. J. 1995. Eukaryotic DNA replication. Curr. Opin. Cell Biol. 7: 414-420.
55. Waseem, N. H. and Lane, D. P. 1990. Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J. Cell Sci. 96: 121-129.
56. Weinberg, D. S. 1992. Proliferation indices in solid tumors. In: Advances in Pathology and Laboratory Medicine. Weinstein, R. S., Graham, A. R., Anderson, R. E., Benson, E. S., Cotran, R. S., Fenoglio-Preiser, C. M. and Zumwalt, R. E., Eds. Mosby Year Book, New York, vol. 5. pp. 163-191.
57. Weinstein, I. B. 1991. Cancer prevention: recent progress and future opportunities. Cancer Res. 51: 5080S-5085s.
58. Wilson, G. D., Dische, S. and Saunders, M. I. 1995. Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy. Radiother. Oncol. 36:189-197.